Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 4 studies | 22% ± 6% | |
squamous epithelial cell | 3 studies | 25% ± 5% | |
epithelial cell | 3 studies | 42% ± 23% | |
hepatocyte | 3 studies | 45% ± 11% |
Insufficient scRNA-seq data for expression of XDH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5636.15 | 226 / 226 | 87% | 26.13 | 355 / 406 |
prostate | 87% | 411.68 | 212 / 245 | 63% | 4.02 | 318 / 502 |
intestine | 52% | 1378.48 | 499 / 966 | 88% | 13.60 | 466 / 527 |
esophagus | 40% | 980.81 | 583 / 1445 | 92% | 17.48 | 169 / 183 |
pancreas | 37% | 42.09 | 122 / 328 | 88% | 14.00 | 157 / 178 |
bladder | 48% | 254.05 | 10 / 21 | 77% | 8.81 | 388 / 504 |
breast | 61% | 555.98 | 278 / 459 | 50% | 8.98 | 561 / 1118 |
stomach | 18% | 46.00 | 66 / 359 | 79% | 9.85 | 226 / 286 |
skin | 88% | 258.98 | 1589 / 1809 | 4% | 0.26 | 19 / 472 |
lung | 13% | 15.27 | 76 / 578 | 78% | 10.77 | 901 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 87% | 9.02 | 39 / 45 |
uterus | 5% | 6.17 | 8 / 170 | 63% | 8.89 | 287 / 459 |
thymus | 37% | 54.95 | 244 / 653 | 19% | 1.33 | 116 / 605 |
ovary | 0% | 0 | 0 / 180 | 50% | 3.46 | 213 / 430 |
kidney | 26% | 44.67 | 23 / 89 | 12% | 1.24 | 109 / 901 |
muscle | 20% | 90.58 | 161 / 803 | 0% | 0 | 0 / 0 |
adipose | 10% | 10.77 | 118 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.38 | 1 / 258 | 3% | 0.29 | 6 / 230 |
blood vessel | 1% | 0.71 | 8 / 1335 | 0% | 0 | 0 / 0 |
spleen | 0% | 4.47 | 1 / 241 | 0% | 0 | 0 / 0 |
heart | 0% | 0.24 | 2 / 861 | 0% | 0 | 0 / 0 |
brain | 0% | 0.09 | 3 / 2642 | 0% | 0 | 0 / 705 |
peripheral blood | 0% | 0.30 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0009114 | Biological process | hypoxanthine catabolic process |
GO_0006204 | Biological process | IMP catabolic process |
GO_0006161 | Biological process | deoxyguanosine catabolic process |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006196 | Biological process | AMP catabolic process |
GO_0006157 | Biological process | deoxyadenosine catabolic process |
GO_0046038 | Biological process | GMP catabolic process |
GO_0000255 | Biological process | allantoin metabolic process |
GO_0006149 | Biological process | deoxyinosine catabolic process |
GO_0006147 | Biological process | guanine catabolic process |
GO_1900745 | Biological process | positive regulation of p38MAPK cascade |
GO_0045602 | Biological process | negative regulation of endothelial cell differentiation |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0046059 | Biological process | dAMP catabolic process |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0043605 | Biological process | amide catabolic process |
GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
GO_0016226 | Biological process | iron-sulfur cluster assembly |
GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
GO_0006154 | Biological process | adenosine catabolic process |
GO_0009115 | Biological process | xanthine catabolic process |
GO_0006148 | Biological process | inosine catabolic process |
GO_0046055 | Biological process | dGMP catabolic process |
GO_2001213 | Biological process | negative regulation of vasculogenesis |
GO_1900747 | Biological process | negative regulation of vascular endothelial growth factor signaling pathway |
GO_0007595 | Biological process | lactation |
GO_0005615 | Cellular component | extracellular space |
GO_0005777 | Cellular component | peroxisome |
GO_0005829 | Cellular component | cytosol |
GO_0016529 | Cellular component | sarcoplasmic reticulum |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0071949 | Molecular function | FAD binding |
GO_0004855 | Molecular function | xanthine oxidase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0043546 | Molecular function | molybdopterin cofactor binding |
GO_0070675 | Molecular function | hypoxanthine oxidase activity |
GO_0070674 | Molecular function | hypoxanthine dehydrogenase activity |
GO_0051537 | Molecular function | 2 iron, 2 sulfur cluster binding |
GO_0004854 | Molecular function | xanthine dehydrogenase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | XDH |
Protein name | Xanthine dehydrogenase/oxidase Uncharacterized protein XDH Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)] |
Synonyms | XDHA |
Description | FUNCTION: Key enzyme in purine degradation. Catalyzes the oxidation of hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric acid. Contributes to the generation of reactive oxygen species. Has also low oxidase activity towards aldehydes (in vitro). . |
Accessions | Q585T6 ENST00000379416.4 P47989 A0AA96C912 |